ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 147 filers reported holding ASCENDIS PHARMA A/S in Q4 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $958,412 | +8.2% | 10,235 | +3.2% | 0.62% | +15.9% |
| Q2 2023 | $885,412 | +11.5% | 9,921 | +34.0% | 0.53% | +5.5% |
| Q1 2023 | $793,903 | -10.4% | 7,404 | +2.1% | 0.51% | -18.1% |
| Q4 2022 | $885,926 | -7.0% | 7,254 | -21.4% | 0.62% | -9.8% |
| Q3 2022 | $953,000 | -18.2% | 9,227 | -26.4% | 0.68% | -17.3% |
| Q2 2022 | $1,165,000 | -29.4% | 12,529 | -10.9% | 0.83% | -20.5% |
| Q1 2022 | $1,651,000 | +22.6% | 14,065 | +40.5% | 1.04% | +30.6% |
| Q4 2021 | $1,347,000 | -39.0% | 10,009 | -27.8% | 0.80% | -44.3% |
| Q3 2021 | $2,210,000 | +52.8% | 13,868 | +26.2% | 1.43% | +46.0% |
| Q2 2021 | $1,446,000 | +8.6% | 10,991 | +6.3% | 0.98% | -0.2% |
| Q1 2021 | $1,332,000 | -4.0% | 10,339 | +24.3% | 0.98% | -11.0% |
| Q4 2020 | $1,387,000 | +18.9% | 8,316 | +10.0% | 1.10% | +3.0% |
| Q3 2020 | $1,167,000 | +1.3% | 7,561 | -2.9% | 1.07% | -6.0% |
| Q2 2020 | $1,152,000 | +22.8% | 7,789 | -6.5% | 1.14% | +1.3% |
| Q1 2020 | $937,803 | -34.7% | 8,328 | -19.3% | 1.13% | -18.8% |
| Q4 2019 | $1,436,000 | – | 10,323 | – | 1.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 1,797,745 | $265,886,000 | 19.06% |
| RA Capital Management | 4,914,955 | $726,922,000 | 14.16% |
| Sofinnova Investments, Inc. | 1,109,874 | $164,150,000 | 10.35% |
| Eventide Asset Management | 1,709,848 | $252,887,000 | 5.50% |
| Asymmetry Capital Management, L.P. | 47,599 | $7,040,000 | 5.39% |
| BERYLSON CAPITAL PARTNERS, LLC | 58,200 | $8,608,000 | 5.30% |
| Avoro Capital Advisors LLC | 1,750,000 | $258,825,000 | 5.12% |
| Eversept Partners, LP | 220,344 | $32,588,878 | 4.47% |
| Spyglass Capital Management LLC | 452,104 | $66,866,000 | 4.14% |
| Orbimed Advisors | 1,562,986 | $231,166,000 | 3.25% |